April 18, 2019 — A recent study found patients with atherosclerotic cardiovascular disease cut their risk of a second ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
April 16, 2019 — HonorHealth Research Institute announced the first patients have been enrolled in the SynIVUS-DAPT ...
April 15, 2019 — Despite national guidelines indicating statins can lower risk of heart attack and stroke, many patients ...
March 29, 2019 — The cardiovascular benefits of the diabetes drug dapagliflozin extend across a wide spectrum of ...
March 29, 2019 — Taking a high dose of icosapent ethyl significantly reduces the occurrence of first, subsequent and ...
March 25, 2019 — Patients who stopped taking aspirin one month after receiving a stent in the heart’s arteries but ...
March 25, 2019 — Phase 3 results from Study 2, also known as CLEAR WISDOM, of bempedoic acid were recently presented at ...
March 19, 2019 — The Bristol-Myers Squibb-Pfizer Alliance announced results from the Phase 4 AUGUSTUS trial evaluating ...
The American College of Cardiology (ACC) released a list of the latest practice-changing presentations at the ACC.19 ...
March 18, 2019 — The choices we make every day can have a lasting effect on our heart and vascular health. Adopting a ...
February 19, 2019 — A new reversible, drug-free antiplatelet therapy could reduce the risk of blood clots and ...
February 1, 2019 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) m ...
January 31, 2019 — Researchers have mapped the active-state structure of the angiotensin II type 1 receptor, the target ...
April 18, 2019